Home
About
Overview
Sharing Data
ORCID
Help
History (2)
Feasibility of administering oblimersen (G3139; Genasense) with imatinib mesylate in patients with imatinib resistant chronic myeloid leukemia--Cancer and leukemia group B study 10107.
Rho-associated kinase activity is a predictor of cardiovascular outcomes.
See All 2 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Rho-associated kinase activity is a predictor of cardiovascular outcomes.
Rho-associated kinase activity is a predictor of cardiovascular outcomes. Hypertension. 2014 Apr; 63(4):856-64.
View in:
PubMed
subject areas
Adult
Aged
Biomarkers
Cardiovascular Diseases
Female
Follow-Up Studies
Humans
Hypertension
Kaplan-Meier Estimate
Male
Middle Aged
Predictive Value of Tests
Prognosis
Retrospective Studies
rho-Associated Kinases
Risk Factors
authors with profiles
James Liao